Rajesh Khanna
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2017First federal award
$2.4MFederal grants as PI7 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
7 awards · $2.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 1, 2021 | NIH | STTR Phase I Targeting the neuropilin-1 receptor (NRP-1)/VEGF-A axis for neuropathic pain | $419K | Regulonix with UNIVERSITY OF ARIZONA |
| Aug 30, 2021 | NIH | STTR Phase I Targeting the neuropilin-1 receptor (NRP-1)/VEGF-A axis for neuropathic pain | $419K | Regulonix |
| Apr 26, 2021 | NIH | STTR Phase I Inhibition of CaVα-β interaction with orally available small organic molecules for chronic pain | $400K | Regulonix |
| Sep 17, 2019 | NIH | STTR Phase I Optimization of Betulinic Acid analogs for T-type calcium channel inhibition for non-addictive relief of chronic pain | $225K | Regulonix |
| Sep 17, 2019 | NIH | STTR Phase I Discovery of T-type Calcium Channel Antagonists from Multicomponent Reactions and Their Application in Paclitaxel-induced Peripheral Neuropathy | $342K | Regulonix |
| May 1, 2017 | NIH | STTR Phase I Regulators of NaV Channels Novel Anti Allodynic Drug Candidates | $300K | Regulonix with UNIVERSITY OF ARIZONA |
| Apr 19, 2017 | NIH | STTR Phase I Regulators of NaV1.7 Channels: Novel Anti-Allodynic Drug Candidates | $300K | Regulonix |
Peer ranks
Federal funding#814
Awards as PI#250
Patents#273
Companies
- RegulonixLinked by awards · Biotech
Research institutions
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.